Syros Pharmaceuticals Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Feb '26 Feb 10, 2026	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Market Capitalization	0	159	60	149	364	221
Market Cap Growth	-99.91%	163.93%	-59.59%	-59.03%	64.41%	50.55%
Enterprise Value	1	120	-90	74	330	156
Last Close Price	0.00	6.04	2.84	25.09	87.60	97.93
PS Ratio	0.01	20.39	4.88	8.60	32.93	147.97
PB Ratio	0.00	12.16	0.57	2.37	5.49	3.70
P/TBV Ratio	-	12.16	0.57	2.37	5.49	3.70
EV/Sales Ratio	5.07	15.38	-	4.29	29.86	104.14
Debt / Equity Ratio	-5.41	3.73	0.50	0.77	0.73	0.33
Net Debt / Equity Ratio	-0.17	-4.65	-1.09	-0.92	-1.19	-0.83
Net Debt / EBITDA Ratio	-0.02	0.62	1.12	0.81	1.36	0.87
Net Debt / FCF Ratio	-0.02	0.70	1.12	0.78	1.78	0.90
Asset Turnover	0.00	0.05	0.07	0.12	0.08	0.02
Quick Ratio	2.05	3.80	6.63	4.23	6.16	4.75
Current Ratio	2.25	3.95	6.87	4.34	6.24	4.87
Return on Equity (ROE)	-776.96%	-227.95%	-88.90%	-98.49%	-99.02%	-95.63%
Return on Assets (ROA)	-59.88%	-38.32%	-36.95%	-31.37%	-28.32%	-37.85%
Return on Capital Employed (ROCE)	-197.00%	-96.20%	-59.10%	-65.70%	-44.60%	-61.50%
Earnings Yield	-1852663.77%	-81.23%	-130.36%	-42.86%	-16.91%	-25.72%
FCF Yield	-1895071.53%	-54.29%	-171.19%	-49.91%	-12.21%	-24.86%
Buyback Yield / Dilution	-31.77%	-124.24%	-102.00%	-35.79%	-14.49%	-23.17%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.